Aspergillus galactomannan index: A surrogate end point to assess outcome of therapy?

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1423-1425
Number of pages3
JournalClinical Infectious Diseases
Volume46
Issue number9
DOIs
StatePublished - May 1 2008
Externally publishedYes

Fingerprint

Mannans
Aspergillosis
Aspergillus
Biomarkers
Therapeutics
galactomannan

ASJC Scopus subject areas

  • Immunology

Cite this

Aspergillus galactomannan index : A surrogate end point to assess outcome of therapy? / Marr, Kieren.

In: Clinical Infectious Diseases, Vol. 46, No. 9, 01.05.2008, p. 1423-1425.

Research output: Contribution to journalArticle

@article{a2bb5dc33e334ebb869ca8792b9eb97c,
title = "Aspergillus galactomannan index: A surrogate end point to assess outcome of therapy?",
author = "Kieren Marr",
year = "2008",
month = "5",
day = "1",
doi = "10.1086/528715",
language = "English (US)",
volume = "46",
pages = "1423--1425",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Aspergillus galactomannan index

T2 - A surrogate end point to assess outcome of therapy?

AU - Marr, Kieren

PY - 2008/5/1

Y1 - 2008/5/1

UR - http://www.scopus.com/inward/record.url?scp=42549102823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549102823&partnerID=8YFLogxK

U2 - 10.1086/528715

DO - 10.1086/528715

M3 - Article

C2 - 18419446

AN - SCOPUS:42549102823

VL - 46

SP - 1423

EP - 1425

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 9

ER -